Status:

COMPLETED

The Women's Recovery Group Study: Stage I Trial

Lead Sponsor:

Mclean Hospital

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Alcohol-Related Disorders

Substance-Related Disorders

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

The purpose of this study was to develop a gender-specific 12-session, manual-based relapse prevention group for women with substance use disorders (SUDs).

Detailed Description

This Phase I trial compares single-gender Women's Recovery Group (WRG) and an effective control condition, mixed-gender Group Drug Counseling (GDC). WRG is a new 12-session women-focused, manual-based...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Participants were included in the study if they:
  • were diagnosed with at least one substance dependence other than nicotine dependence based on the Structured Clinical Interview for DSM-IV at the time of enrollment
  • used substances within 60 days of baseline assessment
  • were 18 years of age or older
  • expressed intention to remain within the geographic area to return for follow-up assessments
  • signed permission for the research team to communicate with any other mental health professional from whom they were receiving care
  • Patients were excluded if they:
  • had certain co-occurring diagnoses (i.e., bipolar, post-traumatic stress, or psychotic disorders) at the time of enrollment
  • were mandated to treatment
  • were in residential treatment restricting substance use during the group treatment phase
  • participated in concurrent substance abuse treatment group (not including self-help) during the 12-week group treatment phase
  • showed clinical indication for medical detoxification (these patients were eligible to enter the study after detoxification)

Exclusion

    Key Trial Info

    Start Date :

    March 1 2003

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2005

    Estimated Enrollment :

    46 Patients enrolled

    Trial Details

    Trial ID

    NCT00230100

    Start Date

    March 1 2003

    End Date

    October 1 2005

    Last Update

    November 1 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    McLean Hospital

    Belmont, Massachusetts, United States, 02478 9106